Specific sequence determinants of miR-15/107 microRNA gene group targets. [Anonymous]. 2011. Specific sequence determinants of miR-15/107 microRNA gene group targets.. Nucleic acids research. 39(18):8163-72.
Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease. [Anonymous]. 2011. Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease.. PloS one. 6(7):e22585.
Biomarkers and evolution in Alzheimer disease. [Anonymous]. 2011. Biomarkers and evolution in Alzheimer disease.. Progress in neurobiology. 95(4):510-3.
Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options. [Anonymous]. 2011. Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.. Neurodegenerative disease management. 1(2):141-156.
Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study. [Anonymous]. 2011. Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study.. Journal of neuropathology and experimental neurology. 70(10):832-40.
Frontal cortex neuropathology in dementia pugilistica. [Anonymous]. 2012. Frontal cortex neuropathology in dementia pugilistica.. Journal of neurotrauma. 29(6):1054-70.
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. [Anonymous]. 2012. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.. Acta neuropathologica. 123(1):1-11.
Widespread suppression of huntingtin with convection-enhanced delivery of siRNA. [Anonymous]. 2012. Widespread suppression of huntingtin with convection-enhanced delivery of siRNA.. Experimental neurology. 233(1):463-71.
Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. [Anonymous]. 2012. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.. Experimental neurology. 235(2):491-6.
Studying microRNAs in the brain: technical lessons learned from the first ten years. [Anonymous]. 2012. Studying microRNAs in the brain: technical lessons learned from the first ten years.. Experimental neurology. 235(2):397-401.
